(Q41663598)

6 October 2017

title

Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney Disease (English)

1 reference

6 October 2017

0 references

1 reference

P-C Wu

1

1 reference

6 October 2017

C-J Wu

2

1 reference

6 October 2017

C-J Lin

3

1 reference

6 October 2017

C-F Pan

4

1 reference

6 October 2017

C-Y Chen

5

1 reference

6 October 2017

T-M Huang

6

1 reference

6 October 2017

C-H Wu

7

1 reference

6 October 2017

S-L Lin

8

1 reference

6 October 2017

Y-M Chen

9

1 reference

6 October 2017

L Chen

10

1 reference

6 October 2017

V-C Wu

11

1 reference

6 October 2017

NSARF Group

12

1 reference

6 October 2017

Kidney Consortium

13

1 reference

6 October 2017

language of work or name

English

0 references

publication date

16 June 2015

1 reference

Clinical Pharmacology & Therapeutics

6 October 2017

published in

1 reference

6 October 2017

volume

98

1 reference

6 October 2017

issue

4

1 reference

6 October 2017

page(s)

442-449

1 reference

Combining GFR and albuminuria to classify CKD improves prediction of ESRD.

6 October 2017

cites work

1 reference

Relation between kidney function, proteinuria, and adverse outcomes

21 January 2018

1 reference

Mechanisms and treatment of CKD.

21 January 2018

1 reference

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

Pentoxifylline: a potential therapy for chronic kidney disease.

21 January 2018

1 reference

Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders

21 January 2018

1 reference

Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients.

21 January 2018

1 reference

Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial

21 January 2018

1 reference

Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure

21 January 2018

1 reference

Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial

21 January 2018

1 reference

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration

21 January 2018

1 reference

Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.

21 January 2018

1 reference

Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.

21 January 2018

1 reference

Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

Effects of pentoxifylline on inflammatory parameters in chronic kidney disease patients: a randomized trial.

21 January 2018

1 reference

The renoprotective potential of pentoxifylline in chronic kidney disease.

21 January 2018

1 reference

Use of pentoxifylline in membranous nephropathy

21 January 2018

1 reference

Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study

21 January 2018

1 reference

Effects of losartan and pentoxifylline on renal dimethylarginine dimethylaminohydrolase-1 expression in proteinuric nephropathy

21 January 2018

1 reference

The cardiorenal syndrome: what the cardiologist needs to know

21 January 2018

1 reference

RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection

21 January 2018

1 reference

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan.

21 January 2018

1 reference

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial

21 January 2018

1 reference

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

21 January 2018

1 reference

Off the beaten renin-angiotensin-aldosterone system pathway: new perspectives on antiproteinuric therapy

21 January 2018

1 reference

Administrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in Taiwan

21 January 2018

1 reference

Long-term risk of coronary events after AKI.

21 January 2018

1 reference

Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan

21 January 2018

1 reference

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia

21 January 2018

1 reference

Risk of developing severe sepsis after acute kidney injury: a population-based cohort study

21 January 2018

1 reference

The secret of immortal time bias in epidemiologic studies.

21 January 2018

1 reference

Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies

21 January 2018

1 reference

Estimation of propensity scores using generalized additive models

21 January 2018

1 reference

Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study

21 January 2018

1 reference

7 January 2021

Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria: a double-blind, placebo-controlled randomized trial.

1 reference

7 January 2021

Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease

1 reference

7 January 2021

The impact of acute kidney injury with temporary dialysis on the risk of fracture

1 reference

7 January 2021

Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality

1 reference

7 January 2021

Identifiers

DOI

10.1002/CPT.173

1 reference

6 October 2017

1 reference